KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Cash & Current Investments: 2009-2014

Historic Cash & Current Investments for Biocryst Pharmaceuticals (BCRX) over the last 6 years, with Dec 2014 value amounting to $72.8 million.

  • Biocryst Pharmaceuticals' Cash & Current Investments fell 44.68% to $70.3 million in Q3 2015 from the same period last year, while for Sep 2015 it was $305.0 million, marking a year-over-year decrease of 7.21%. This contributed to the annual value of $72.8 million for FY2014, which is 91.23% up from last year.
  • Per Biocryst Pharmaceuticals' latest filing, its Cash & Current Investments stood at $72.8 million for FY2014, which was up 91.23% from $38.1 million recorded in FY2013.
  • Over the past 5 years, Biocryst Pharmaceuticals' Cash & Current Investments peaked at $72.8 million during FY2014, and registered a low of $35.6 million during FY2012.
  • Moreover, its 3-year median value for Cash & Current Investments was $38.1 million (2013), whereas its average is $48.8 million.
  • In the last 5 years, Biocryst Pharmaceuticals' Cash & Current Investments fell by 22.67% in 2011 and then soared by 91.23% in 2014.
  • Biocryst Pharmaceuticals' Cash & Current Investments (Yearly) stood at $53.9 million in 2010, then dropped by 22.67% to $41.7 million in 2011, then declined by 14.67% to $35.6 million in 2012, then climbed by 6.90% to $38.1 million in 2013, then spiked by 91.23% to $72.8 million in 2014.